These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8825458)

  • 41. Proteus vulgaris agglutination by cystic fibrosis sera.
    Wang A; Turner MW; Soothill JF; Warner JO; Norman AP
    Arch Dis Child; 1980 Feb; 55(2):130-3. PubMed ID: 6990879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sodium transport in cystic fibrosis fibroblasts.
    N Engl J Med; 1981 Apr; 304(16):974-6. PubMed ID: 7207549
    [No Abstract]   [Full Text] [Related]  

  • 43. Screening for cystic fibrosis carriers.
    Schulman JD; Maddalena A; Black SH; Bick DP
    Am J Hum Genet; 1990 Oct; 47(4):740. PubMed ID: 2220812
    [No Abstract]   [Full Text] [Related]  

  • 44. Detection of cystic-fibrosis genotypes.
    Katznelson D; Blau H; Sack J
    Lancet; 1983 Sep; 2(8350):622. PubMed ID: 6136766
    [No Abstract]   [Full Text] [Related]  

  • 45. Cascade carrier-testing in cystic fibrosis.
    Roberts T; Schwarz MJ; Kerr-Liddell R; Hinks JL; Super M
    Paediatr Respir Rev; 2003 Dec; 4(4):293-8. PubMed ID: 14629951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benchmarks for cystic fibrosis carrier screening: a European consensus document.
    Castellani C; Macek M; Cassiman JJ; Duff A; Massie J; ten Kate LP; Barton D; Cutting G; Dallapiccola B; Dequeker E; Girodon E; Grody W; Highsmith EW; Kääriäinen H; Kruip S; Morris M; Pignatti PF; Pypops U; Schwarz M; Soller M; Stuhrman M; Cuppens H
    J Cyst Fibros; 2010 May; 9(3):165-78. PubMed ID: 20363197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carrier detection and clinical uncertainty: the case for public health ethics.
    Miller FA; Hayeems RZ; Robert JS
    Am J Public Health; 2009 Aug; 99(8):1349-50. PubMed ID: 19542029
    [No Abstract]   [Full Text] [Related]  

  • 48. Population-based genetic screening for cystic fibrosis: attitudes and outcomes.
    Ioannou L; Massie J; Collins V; McClaren B; Delatycki MB
    Public Health Genomics; 2010; 13(7-8):449-56. PubMed ID: 20090299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carrier screening for cystic fibrosis: costs and clinical outcomes.
    Asch DA; Hershey JC; Dekay ML; Pauly MV; Patton JP; Jedrziewski MK; Frei F; Giardine R; Kant JA; Mennuti MT
    Med Decis Making; 1998; 18(2):202-12. PubMed ID: 9566453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic variability in five cystic fibrosis patients compound heterozygous for the Y1092X mutation.
    De Braekeleer M; Allard C; Leblanc JP; Simard F; Aubin G
    Hum Hered; 1998; 48(3):158-62. PubMed ID: 9618063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Screening for gene carrier state of cystic fibrosis: pros and cons of various scenarios].
    Kooij L
    Ned Tijdschr Geneeskd; 1994 Apr; 138(16):818-23. PubMed ID: 8183386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Challenges in providing residual risks in carrier testing.
    Nussbaum RL; Slotnick RN; Risch NJ
    Prenat Diagn; 2021 Aug; 41(9):1049-1056. PubMed ID: 34057205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A universal array-based multiplexed test for cystic fibrosis carrier screening.
    Amos JA; Bridge-Cook P; Ponek V; Jarvis MR
    Expert Rev Mol Diagn; 2006 Jan; 6(1):15-22. PubMed ID: 16359263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preconceptional couple screening for cystic fibrosis carrier status: couples prefer full disclosure of test results.
    Henneman L; Ten Kate LP
    J Med Genet; 2002 May; 39(5):E26. PubMed ID: 12011167
    [No Abstract]   [Full Text] [Related]  

  • 55. Screening for cystic fibrosis carrier state.
    Mennuti MT; Thomson E; Press N
    Obstet Gynecol; 1999 Mar; 93(3):456-61. PubMed ID: 10075000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CFTR mutation screening in an assisted reproductive clinic.
    Field PD; Martin NJ
    Aust N Z J Obstet Gynaecol; 2011 Dec; 51(6):536-9. PubMed ID: 21875427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preconceptional cystic fibrosis carrier screening: opinions of general practitioners, gynecologists, and pediatricians in the Netherlands.
    Baars MJ; Henneman L; ten Kate LP
    Genet Test; 2004; 8(4):431-6. PubMed ID: 15684876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Screening for carriers of cystic fibrosis. Result of a pilot study among pregnant women].
    Brandt NJ; Schwartz M; Skovby F
    Ugeskr Laeger; 1994 Jun; 156(25):3751-4, 3757. PubMed ID: 8059452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heteroduplex formation in polymerase chain reaction.
    Anglani F; Picci L; Camporese C; Zacchello F
    Am J Hum Genet; 1990 Jul; 47(1):169-70. PubMed ID: 2349948
    [No Abstract]   [Full Text] [Related]  

  • 60. 'It is not in my world': an exploration of attitudes and influences associated with cystic fibrosis carrier screening.
    McClaren BJ; Delatycki MB; Collins V; Metcalfe SA; Aitken M
    Eur J Hum Genet; 2008 Apr; 16(4):435-44. PubMed ID: 18059419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.